5-110420724-T-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001039763.4(TMEM232):c.1830A>T(p.Glu610Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000137 in 1,525,222 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001039763.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM232 | NM_001039763.4 | c.1830A>T | p.Glu610Asp | missense_variant | 14/14 | ENST00000455884.7 | NP_001034852.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM232 | ENST00000455884.7 | c.1830A>T | p.Glu610Asp | missense_variant | 14/14 | 2 | NM_001039763.4 | ENSP00000401477 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000782 AC: 119AN: 152160Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000112 AC: 14AN: 124794Hom.: 0 AF XY: 0.000132 AC XY: 9AN XY: 67964
GnomAD4 exome AF: 0.0000634 AC: 87AN: 1372944Hom.: 1 Cov.: 30 AF XY: 0.0000532 AC XY: 36AN XY: 677112
GnomAD4 genome AF: 0.000801 AC: 122AN: 152278Hom.: 0 Cov.: 32 AF XY: 0.000806 AC XY: 60AN XY: 74472
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 05, 2023 | The c.1830A>T (p.E610D) alteration is located in exon 14 (coding exon 13) of the TMEM232 gene. This alteration results from a A to T substitution at nucleotide position 1830, causing the glutamic acid (E) at amino acid position 610 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at